Page last updated: 2024-08-17

caramiphen and cyclopentane

caramiphen has been researched along with cyclopentane in 96 studies

Research

Studies (96)

Timeframe	Studies, this research(%)	All Research%
pre-1990	62 (64.58)	18.7374
1990's	14 (14.58)	18.2507
2000's	5 (5.21)	29.6817
2010's	14 (14.58)	24.3611
2020's	1 (1.04)	2.80

Authors

Authors	Studies
Chou, DT; Wallenstein, MC; Wang, SC	1
Bak, W; Borkowska, G; Faff, J; Rump, S; Szymańska, T	1
Baimbridge, KG; Church, J; Shacklock, JA	1
Annels, SJ; Davies, JA; Ellis, Y	1
DeHaven-Hudkins, DL; Hudkins, RL; Stubbins, JF	2
Apland, JP; Braitman, DJ	1
Braitman, DJ; Brennecke, LH; Sparenborg, S	1
Musacchio, JM; Tortella, FC; Witkin, JM	1
Yu, YX; Zhang, LM	1
Domino, EF; Krutak-Krol, H; Lal, J	1
Flanagan, T; Levandoski, P	1
Grünthal, E	2
Diana, G; Pezzola, A; Popoli, P; Sagratella, S; Scotti de Carolis, A	1
Allen, JT; DeHaven-Hudkins, DL; Hudkins, RL; Stubbins, JF; Tortella, FC	1
Katz, JL; Sharpe, LG; Székely, JI	1
Domenici, MR; Frank, C; Sagratella, S; Scotti de Carolis, A	1
Allen, JT; DeHaven-Hudkins, DL; Ford-Rice, FY; Hudkins, RL	1
Baragatti, G; Dematteis, M; Gavend, M; Mallaret, M	1
Alkalay, D; Chapman, S; Cohen, G; Gilat, E; Rabinovitz, I; Raveh, L; Weissman, BA	1
Alkalay, D; Brandeis, R; Cohen, G; Rabinovitz, I; Raveh, L; Sonego, H; Weissman, BA	1
SNYDER, GG	1
GLICK, J	1
BOYSEN, KH	1
HORAUF, A; MECHELKE, K	1
BEHREND, RC	1
OTTLIK, H	1
PULVER, R	1
GOKAY, FK; TUKEL, K	1
HERRLIN, KM; MELIN, KA	1
ANDRIEU, B; DELGA, J	1
CARTER, S; MERRITT, HH; SCIARRA, D	1
SANYAL, RK	1
LEIGH, D; SCHWAB, RS	2
DE SCHAEPDRYVER, A	1
JERSILD, T	2
KAERCHER, W; MAURATH, J	1
DROBEC, E; ZEIHSL, E	1
MEIRSMAN-ROOBROECK, GC	1
DIERCKS, AL	1
PAKESCH, EF	1
JORDAN, J; UIBERALL, E	1
WINTHER, K	1
Abraham, S; Cohen, G; Dachir, S; Gilat, E; Herskovitz, M; Kapon, J; Levy, A; Raveh, L; Teitelbaum, Z	1
BORELLINI, A; DAVINI, V	1
KOWALEWSKI, K; MAHAUX, J	2
COBB, CT; LEIGH, D; SCHWAB, RS	1
SCHWAB, RS; TILLMANN, WR	1
DAENINCK, L; LIBBRECHT, L	2
GRUBER, CM; KRAATZ, CP	2
MUNCH-PETERSEN, S	1
DALSGAARD-NIELSEN, T	1
HERMANN, K	1
Brandeis, R; Egoz, I; Gilat, E; Kapon, J; Rabinovitz, I; Raveh, L; Stavitsky, Z; Weissman, BA	1
Aas, P; Enger, S; Myhrer, T	2
Raveh, L; Weissman, BA	2
BICKEL, G; DUBOIS, JP	1
HEUSCHER, JE; SCHOELLY, ML	1
JOACHIMOGLU, G; KLISSIUNIS, N	1
BOOIJ, J	1
HABERMANN, H	1
POLICZER, M	1
BAUD, C; FLEISCH, A	1
LANINI, G; LEHNER, F	1
DUNHAM, WF; EDWARDS, CH	1
DE VLEESCHHOUWER, GR; HEYMANS, C	3
FLEISCH, A; GRANDJEAN, E	1
Chen, YC; Chen, YW; Chu, CC; Hung, CH; Wang, JJ	1
HARTMANN, K	2
MONAKOW, KH	1
Honda, S; Kawaura, K; Shirasaki, T; Soeda, F; Takahama, K	1
Honda, S; Kawaura, K; Miki, R; Shima, E; Shirasaki, T; Soeda, F; Takahama, K	1
Apland, JP; Aroniadou-Anderjaska, V; Braga, MF; Ferrara, TM; Figueiredo, TH; Pidoplichko, V; Qashu, F; Stevens, D	1
Aas, P; Enger, S; Jonassen, M; Myhrer, T	1
Kelley, NR; Lee, RB; Lumley, LA; Moffett, MC; Schultz, MK; Schwartz, JE; Stone, MF; Wright, LK	1
Bloch-Shilderman, E; Brandeis, R; Egoz, I; Grauer, E; Katalan, S; Lazar, S; Rabinovitz, I; Raveh, L	1
Patil, SP	1
Eisenkraft, A; Raveh, L; Weissman, BA	1
Chen, YW; Gong, CL; Leung, YM; Tzeng, JI; Wang, JJ; Wang, YW	1
Apland, JP; Aroniadou-Anderjaska, V; Braga, MFM; Figueiredo, TH; Pidoplichko, VI; Rossetti, K	1
Apland, JP; Aroniadou-Anderjaska, V; Braga, MFM; De Araujo Furtado, M; Figueiredo, TH	2

Reviews

5 review(s) available for caramiphen and cyclopentane

Article	Year
Discriminative stimulus properties of dextromethorphan in rats. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1995, Volume: 49, Issue:10 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Antitussive Agents; Cyclazocine; Cyclopentanes; Dextromethorphan; Dextrorphan; Discrimination Learning; Dizocilpine Maleate; Dose-Response Relationship, Drug; Male; Morphine; Neuroprotective Agents; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, sigma	1995
Therapy against organophosphate poisoning: the importance of anticholinergic drugs with antiglutamatergic properties. Toxicology and applied pharmacology, 2008, Oct-15, Volume: 232, Issue:2 Topics: Animals; Cholinergic Antagonists; Cholinesterase Inhibitors; Cyclopentanes; Excitatory Amino Acid Antagonists; Gas Poisoning; Glutamic Acid; Humans; Organophosphate Poisoning; Organophosphates	2008
[Novel antidepressant-like action of drugs possessing GIRK channel blocking action in rats]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2010, Volume: 130, Issue:5 Topics: Animals; Antidepressive Agents; Biogenic Monoamines; Brain; Cyclopentanes; Disease Models, Animal; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Humans; Male; Piperidines; Rats; Rats, Wistar	2010
Multifunctional drugs as novel antidotes for organophosphates' poisoning. Toxicology, 2011, Dec-18, Volume: 290, Issue:2-3 Topics: Acetylcholine; Animals; Antidotes; Atropine; Cholinergic Antagonists; Cyclopentanes; Excitatory Amino Acid Antagonists; Humans; Muscarinic Antagonists; Organophosphate Poisoning; Poisoning; Scopolamine	2011
Caramiphen edisylate: an optimal antidote against organophosphate poisoning. Toxicology, 2014, Nov-05, Volume: 325 Topics: Acetylcholine; Animals; Antidotes; Brain; Chemical Warfare Agents; Cholinesterase Inhibitors; Cyclopentanes; Humans; Neuroprotective Agents; Organophosphate Poisoning	2014

Trials

1 trial(s) available for caramiphen and cyclopentane

Article	Year
Caramiphen and scopolamine prevent soman-induced brain damage and cognitive dysfunction. Neurotoxicology, 2002, Volume: 23, Issue:1 Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cognition Disorders; Cyclopentanes; Escape Reaction; Hypoxia, Brain; Male; Maze Learning; Prosencephalon; Rats; Rats, Sprague-Dawley; Reaction Time; Scopolamine; Soman; Swimming	2002

Other Studies

90 other study(ies) available for caramiphen and cyclopentane

Article	Year
Studies on the potency of various antitussive agents. Agents and actions, 1977, Volume: 7, Issue:3 Topics: Animals; Antitussive Agents; Cats; Clonazepam; Codeine; Cough; Cyclopentanes; Dextromethorphan; Diazepam; Ethylamines; Injections, Intravenous	1977
Efficacy of repeated pharmacotherapy in experimental acute poisonings with fluostigmine. Archives of toxicology, 1976, Aug-18, Volume: 35, Issue:4 Topics: Animals; Antidotes; Atropine; Cyclopentanes; Diazepam; Diethylamines; Isoflurophate; Obidoxime Chloride; Rats	1976
Dextromethorphan and phencyclidine receptor ligands: differential effects on K(+)- and NMDA-evoked increases in cytosolic free Ca2+ concentration. Neuroscience letters, 1991, Apr-01, Volume: 124, Issue:2 Topics: Animals; Calcium; Cyclopentanes; Cytosol; Dextromethorphan; Female; Fura-2; Hippocampus; Ketamine; Ligands; N-Methylaspartate; Parasympatholytics; Potassium; Pregnancy; Pyramidal Tracts; Rats; Receptors, Neurotransmitter; Receptors, Phencyclidine	1991
Non-opioid antitussives inhibit endogenous glutamate release from rabbit hippocampal slices. Brain research, 1991, Nov-15, Volume: 564, Issue:2 Topics: Animals; Antitussive Agents; Aspartic Acid; Cyclopentanes; Depression, Chemical; Dextromethorphan; Female; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Glycine; Hippocampus; In Vitro Techniques; Male; Potassium; Rabbits	1991
Muscarinic receptor binding profile of para-substituted caramiphen analogues. Journal of medicinal chemistry, 1991, Volume: 34, Issue:10 Topics: Animals; Binding, Competitive; Cerebral Cortex; Cyclopentanes; Male; Molecular Structure; Parasympatholytics; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Structure-Activity Relationship	1991
Effects of non-opioid antitussives on epileptiform activity and NMDA responses in hippocampal and olfactory cortex slices. Brain research, 1990, Oct-08, Volume: 529, Issue:1-2 Topics: Animals; Antitussive Agents; Cyclopentanes; Dextromethorphan; Electric Stimulation; Epilepsy; Evoked Potentials; Guinea Pigs; Hippocampus; In Vitro Techniques; Magnesium; N-Methylaspartate; Olfactory Bulb	1990
Prevention of soman neurotoxicity by non-opioid antitussives. Neurotoxicology, 1990,Fall, Volume: 11, Issue:3 Topics: Animals; Anticonvulsants; Antitussive Agents; Cyclopentanes; Dextromethorphan; Guinea Pigs; Male; Necrosis; Nervous System Diseases; Neurons; Soman	1990
Caramiphen: a non-opioid antitussive with potent anticonvulsant properties in rats. European journal of pharmacology, 1988, Oct-11, Volume: 155, Issue:1-2 Topics: Animals; Anticonvulsants; Antitussive Agents; Atropine; Behavior, Animal; Cyclopentanes; Electroshock; Injections, Subcutaneous; Male; Phenytoin; Physostigmine; Rats; Rats, Inbred Strains; Time Factors	1988
[Studies on the fluorometric ion pair method for the determination of several tertiary amines]. Yao xue xue bao = Acta pharmaceutica Sinica, 1985, Volume: 20, Issue:10 Topics: Amines; Anthracenes; Benzoates; Benztropine; Cyclopentanes; Indicators and Reagents; Ions; Spectrometry, Fluorescence	1985
Evidence for a central site of action for the antitussive effects of caramiphen. The Journal of pharmacology and experimental therapeutics, 1985, Volume: 233, Issue:1 Topics: Animals; Antitussive Agents; Brain Stem; Cats; Cough; Cyclopentanes; Decerebrate State; Dextromethorphan; Female	1985
Use of nitrogen-specific detector for GLC determination of caramiphen in whole blood. Journal of pharmaceutical sciences, 1980, Volume: 69, Issue:11 Topics: Antitussive Agents; Chromatography, Gas; Cyclopentanes; Humans	1980
[Scientific raisins from 125 years SMW (Swiss Medical Weekly). On Parpanit, a new agents which modifies extrapyramidal motor disorders. 1946]. Schweizerische medizinische Wochenschrift, 1995, Oct-14, Volume: 125, Issue:41 Topics: Antiparkinson Agents; Basal Ganglia Diseases; Cyclopentanes; History, 20th Century; Humans	1995
Non-opioid antitussives potentiate some behavioural and EEG effects of N-methyl-D-aspartate channel blockers. Life sciences, 1993, Volume: 52, Issue:19 Topics: Animals; Antitussive Agents; Behavior, Animal; Cyclopentanes; Dextromethorphan; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Synergism; Electroencephalography; Ion Channels; Male; Mice; Phencyclidine; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate	1993
Anticonvulsant activity of caramiphen analogs. Life sciences, 1995, Volume: 56, Issue:19 Topics: Animals; Anticonvulsants; Cyclopentanes; Male; Pentazocine; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship	1995
Effects of caramiphen and phencyclidine alone and in combination on behavior in the rat. Pharmacology, biochemistry, and behavior, 1994, Volume: 47, Issue:3 Topics: Animals; Ataxia; Behavior, Animal; Cyclopentanes; Dose-Response Relationship, Drug; Drug Interactions; Male; Motor Activity; Parasympatholytics; Phencyclidine; Rats; Rats, Sprague-Dawley; Stereotyped Behavior	1994
Effects of non-opioid antitussives on hypoxia-induced electrical changes in rat hippocampal slices: a comparative study with anticonvulsant drugs. General pharmacology, 1993, Volume: 24, Issue:4 Topics: Animals; Anticonvulsants; Antitussive Agents; Cyclopentanes; Dizocilpine Maleate; Electrophysiology; Epilepsy; Hippocampus; Hypoxia, Brain; In Vitro Techniques; Male; Membrane Potentials; Phenytoin; Rats; Rats, Wistar	1993
Caramiphen, iodocaramiphen and nitrocaramiphen are potent, competitive, muscarinic M1 receptor-selective agents. European journal of pharmacology, 1993, Feb-16, Volume: 231, Issue:3 Topics: Animals; Binding Sites; Binding, Competitive; Brain; Culture Techniques; Cyclopentanes; Male; Myocardium; Nitro Compounds; Parasympatholytics; Parasympathomimetics; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic	1993
Allosteric modulation of ligand binding to [3H](+)pentazocine-defined sigma recognition sites by phenytoin. Life sciences, 1993, Volume: 53, Issue:1 Topics: Allosteric Regulation; Animals; Binding Sites; Cyclopentanes; Dextromethorphan; Dextrorphan; Guinea Pigs; Ligands; Male; Pentazocine; Phenazocine; Phenytoin; Piperidines; Radioligand Assay; Receptors, sigma; Tritium	1993
The involvement of the NMDA receptor complex in the protective effect of anticholinergic drugs against soman poisoning. Neurotoxicology, 1999, Volume: 20, Issue:4 Topics: Animals; Brain; Cholinesterase Inhibitors; Cyclopentanes; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Electroencephalography; Excitatory Amino Acid Antagonists; Flunitrazepam; In Vitro Techniques; Male; Mice; Mice, Inbred ICR; Parasympatholytics; Protein Binding; Pyridostigmine Bromide; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Scopolamine; Seizures; Soman; Time Factors	1999
An evaluation of caramiphen ethane disulfonate as an antitussive agent. The Laryngoscope, 1953, Volume: 63, Issue:10 Topics: Antitussive Agents; Cough; Cyclopentanes; Ethane	1953
CARAMIPHEN hydrochloride. Journal of the American Medical Association, 1959, Apr-25, Volume: 169, Issue:17 Topics: Cyclopentanes; Parasympatholytics	1959
Codeine vs. caramiphen in cough control. Delaware medical journal, 1963, Volume: 35 Topics: Codeine; Cough; Cyclopentanes; Humans; Parasympatholytics	1963
[Experiences with parpanit in the treatment of dyskinetic states]. Medizinische Klinik, 1950, Sep-01, Volume: 45, Issue:35 Topics: Cyclopentanes; Encephalitis	1950
[Cardiovascular effects of parpanit]. Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie, 1950, Volume: 211, Issue:5 Topics: Cardiovascular System; Cyclopentanes	1950
[Parpanit therapy of extrapyramidal disorders]. Munchener medizinische Wochenschrift (1950), 1951, Jan-05, Volume: 93, Issue:1 Topics: Basal Ganglia Diseases; Cyclopentanes; Parkinsonian Disorders	1951
[An experiment to record the effect of massive doses of parpanit on convulsion in electric shock]. Der Nervenarzt, 1951, Mar-20, Volume: 22, Issue:3 Topics: Convulsive Therapy; Cyclopentanes; Seizures	1951
[Resorption, decomposition and elimination of parpanit in the organism]. Archives internationales de pharmacodynamie et de therapie, 1951, Apr-01, Volume: 86, Issue:2 Topics: Biological Phenomena; Cyclopentanes; Humans; Physiological Phenomena	1951
[Parpanit in therapy of extrapyramidal diseases]. Schweizerische medizinische Wochenschrift, 1951, Jun-16, Volume: 81, Issue:24 Topics: Basal Ganglia Diseases; Cyclopentanes; Extrapyramidal Tracts; Humans	1951
[Parpanit and artane as pediatric antispasmodics]. Nordisk medicin, 1952, Mar-07, Volume: 47, Issue:10 Topics: Cardiovascular Agents; Cerebral Palsy; Cyclopentanes; Muscle Relaxants, Central; Parasympatholytics; Trihexyphenidyl	1952
[Some properties of diethylamino ethyl ester of phenylcyclopentane carbonic acid (parpanit); its destruction and its distribution in the organism]. Therapie, 1951, Volume: 6, Issue:6 Topics: Carbonic Acid; Cardiovascular Agents; Cyclopentanes; Muscle Relaxants, Central	1951
Caramiphen hydrochloride in the treatment of diseases of the basal ganglions. Journal of the American Medical Association, 1949, Dec-24, Volume: 141, Issue:17 Topics: Basal Ganglia; Cyclopentanes; Ganglia; Ganglion Cysts; Humans	1949
A case of Parkinson's disease treated with parpanit. The Indian medical gazette, 1949, Volume: 84, Issue:8 Topics: Cyclopentanes; Parkinson Disease; Parkinsonian Disorders	1949
[Parpanit in the treatment of Parkinson disease (transl)]. Prensa medica argentina, 1949, Dec-09, Volume: 36, Issue:49 Topics: Cyclopentanes; Parkinson Disease; Parkinsonian Disorders	1949
[Pharmacological action on the bronchi of the guinea pig]. Archives internationales de pharmacodynamie et de therapie, 1950, Apr-15, Volume: 82, Issue:2 Topics: Bronchi; Cyclopentanes; Guinea Pigs; Phenothiazines	1950
Congenital spastic paralysis treated with parpanit. Acta paediatrica, 1950, Volume: 39, Issue:1-2 Topics: Cerebral Palsy; Cyclopentanes; Muscle Spasticity; Paralysis	1950
[Effect of parpanit on blood circulation]. Archives internationales de pharmacodynamie et de therapie, 1950, May-15, Volume: 82, Issue:4 Topics: Blood; Blood Vessels; Cyclopentanes	1950
[Treatment of spasticity and local muscular spasm with parpanit]. Praxis, 1950, Jun-01, Volume: 39, Issue:22 Topics: Central Nervous System; Cyclopentanes; Humans; Muscle Spasticity; Muscles; Spasm	1950
The protective action of parpanit, diparcol and some other drugs against chloroform-adrenaline ventricular fibrillation. Archives internationales de pharmacodynamie et de therapie, 1950, Aug-01, Volume: 83, Issue:3 Topics: Arrhythmias, Cardiac; Chloroform; Cyclopentanes; Epinephrine; Humans; Phenothiazines; Ventricular Fibrillation	1950
[Experience with therapeutic use of parpanit]. Nederlands tijdschrift voor geneeskunde, 1950, May-06, Volume: 94, Issue:18 Topics: Cyclopentanes; Parkinsonian Disorders	1950
[Treatment of extrapyramidal motor disturbances]. Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete, 1950, Volume: 31, Issue:6 Topics: Cyclopentanes; Movement; Paralysis; Parkinsonian Disorders	1950
[Modern drugs in the treatment of parkinsonism and similar diseases]. Revista medica de Chile, 1950, Volume: 78, Issue:7 Topics: Cyclopentanes; Mephenesin; Paralysis; Parkinsonian Disorders; Phenothiazines	1950
[Treatment of paralysis agitans with some new preparations: parpanit, diparcol, and phenergan]. Ugeskrift for laeger, 1950, May-25, Volume: 112, Issue:21 Topics: Cyclopentanes; Histamine; Parkinson Disease; Parkinsonian Disorders; Phenothiazines; Promethazine	1950
Extrapolating from animal studies to the efficacy in humans of a pretreatment combination against organophosphate poisoning. Archives of toxicology, 2007, Volume: 81, Issue:5 Topics: Animals; Chemical Warfare Agents; Cholinergic Antagonists; Cyclopentanes; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Infusions, Parenteral; Lethal Dose 50; Male; Metabolic Clearance Rate; Organophosphate Poisoning; Organophosphates; Papio anubis; Poisoning; Pyridostigmine Bromide; Sarin; Species Specificity; Treatment Outcome	2007
Observations on the effect of parpanit on motility disorders from extrapyramidal and pyramidal lesions. Minerva medica, 1948, Oct-27, Volume: 39, Issue:43 Pt 2 Topics: Cyclopentanes; Humans; Parasympatholytics; Pharmaceutical Preparations	1948
Action of the diethylaminoethyl ester of phenyl-cyclopentane-carboxylic acid (parpanit) on basal metabolism and metabolism after the effort of hyperthyroid, hypothyroid and normothyroid subjects. Archives internationales de pharmacodynamie et de therapie, 1948, Sep-01, Volume: 77, Issue:3 Topics: Basal Metabolism; Cyclopentanes	1948
Parpanit in the treatment of Parkinson's disease. Journal of the American Medical Association, 1949, Mar-05, Volume: 139, Issue:10 Topics: Cyclopentanes; Humans; Parkinson Disease; Parkinsonian Disorders	1949
Treatment of Parkinson's disease with parpanit; a preliminary report. Transactions of the American Neurological Association, 1948, Volume: 73, Issue:73 Annual Topics: Cyclopentanes; Humans; Parkinson Disease; Parkinsonian Disorders	1948
Artane in the treatment of Parkinson's disease; a report of its effectiveness alone and in combination with benadryl and parpanit. The New England journal of medicine, 1949, Sep-29, Volume: 241, Issue:13 Topics: Cyclopentanes; Diphenhydramine; Parkinson Disease; Parkinsonian Disorders; Trihexyphenidyl	1949
On the central action of the ethylamino-ethyl ester of phenyl-cyclopentane carboxylic acid, parpanit. Archives internationales de pharmacodynamie et de therapie, 1949, May-01, Volume: 79, Issue:2-3 Topics: Cyclopentanes	1949
The effect of diethylaminoethyl ester of 1-phenylcyclopentane-1-carboxylic acid hydrochloride, parpanit, on decerebrate rigidity, spinal reflexes and skeletal muscle. The Journal of pharmacology and experimental therapeutics, 1949, Volume: 96, Issue:1 Topics: Carboxylic Acids; Cyclopentanes; Decerebrate State; Muscle, Skeletal; Muscles; Reflex	1949
Pharmacologic and toxicologic studies on diethyl aminoethyl ester of 1-phenyl-cyclopentane-1-carboxylic acid hydrochloride, parpanit. The Journal of pharmacology and experimental therapeutics, 1949, Volume: 96, Issue:1 Topics: Carboxylic Acids; Cyclopentanes; Esters	1949
About the preparation parpanite; used for 30 patients with Parkinsonism. Ugeskrift for laeger, 1949, Apr-21, Volume: 111, Issue:16 Topics: Cyclopentanes; Encephalitis; Encephalitis, Arbovirus; Epidemics	1949
Parpanite treatment of paralysis agitans. Ugeskrift for laeger, 1949, Apr-21, Volume: 111, Issue:16 Topics: Cyclopentanes; Encephalitis; Encephalitis, Arbovirus; Epidemics	1949
About parpanite; treatment results spec. by encephalitic parkinsonism. Ugeskrift for laeger, 1949, Apr-21, Volume: 111, Issue:16 Topics: Cyclopentanes; Encephalitis; Encephalitis, Arbovirus; Epidemics	1949
Morbus Little treated with parpanite. Ugeskrift for laeger, 1949, Apr-21, Volume: 111, Issue:16 Topics: Cyclopentanes	1949
Efficacy of antidotal treatment against sarin poisoning: the superiority of benactyzine and caramiphen. Toxicology and applied pharmacology, 2008, Feb-15, Volume: 227, Issue:1 Topics: Animals; Antidotes; Behavior, Animal; Benactyzine; Chemical Warfare Agents; Cholinesterase Inhibitors; Cyclopentanes; Male; Rats; Rats, Sprague-Dawley; Sarin	2008
Antiparkinson drugs used as prophylactics for nerve agents: studies of cognitive side effects in rats. Pharmacology, biochemistry, and behavior, 2008, Volume: 89, Issue:4 Topics: Animals; Antiparkinson Agents; Behavior, Animal; Benactyzine; Biperiden; Cholinergic Antagonists; Cholinesterase Inhibitors; Cognition; Cyclopentanes; Exploratory Behavior; Male; Motor Activity; Neurotoxins; Organophosphorus Compounds; Physostigmine; Procyclidine; Rats; Rats, Wistar; Trihexyphenidyl	2008
Parpanit in the treatment of intentional tremor; multiple sclerosis and upper red kernel syndrome. Revue medicale de la Suisse romande, 1947, Oct-25, Volume: 67, Issue:10 Topics: Cyclopentanes; Humans; Multiple Sclerosis; Sclerosis; Tremor	1947
Contribution to the physiological effects of parpanit and curare based on self-experiments. Schweizerische medizinische Wochenschrift, 1948, May-29, Volume: 78, Issue:21 Topics: Curare; Cyclopentanes	1948
Contribution to the pharmacology of Parpanit and some of its relatives. Schweizerische medizinische Wochenschrift, 1948, May-29, Volume: 78, Issue:21 Topics: Cyclopentanes	1948
The treatment of Parkinson's syndrome with parpanite. Nederlands tijdschrift voor geneeskunde, 1948, Apr-03, Volume: 92, Issue:14 Topics: Cyclopentanes; Parkinsonian Disorders	1948
Experience with the new preparation Parpanit in the treatment of diseases of the extrapyramidal motor system. Der Nervenarzt, 1948, Volume: 19, Issue:5 Topics: Basal Ganglia Diseases; Cyclopentanes; Syndrome	1948
Central action of the methyl amino amino ester of phenyl cyclopentane carboxylic acid (Parpanit). Schweizerische medizinische Wochenschrift, 1948, Sep-18, Volume: 78, Issue:37 Topics: Cyclopentanes	1948
The use of parpanit in rheumatic joint diseases. Schweizerische medizinische Wochenschrift, 1948, Oct-02, Volume: 78, Issue:39 Topics: Arthritis; Cyclopentanes; Rheumatology	1948
The point of impact of the parpanit. Helvetica physiologica et pharmacologica acta, 1948, Volume: 6, Issue:3 Topics: Cyclopentanes	1948
The influence of parpanit on the cellular respiration of the striated muscles. Helvetica physiologica et pharmacologica acta, 1948, Volume: 6, Issue:3 Topics: Cyclopentanes; Muscles	1948
Parkinsonism treated with parpanit. Lancet (London, England), 1948, Nov-06, Volume: 2, Issue:6532 Topics: Cyclopentanes; Parkinsonian Disorders	1948
Study of the influence of the ethylaminoethyl ester of phenyl-cyclopentane-carboxylic acid (parpanit) on the elevation of the combustion of parkinson patients. Schweizerische medizinische Wochenschrift, 1948, Oct-16, Volume: 78, Issue:41 Topics: Cyclopentanes; Parkinsonian Disorders	1948
Pharmacological actions of the ethylaminoethyl ester of phenyl-cyclopentane-carboxylic acid (parpanit). Archives internationales de pharmacodynamie et de therapie, 1948, Jan-15, Volume: 75, Issue:3-4 Topics: Cyclopentanes	1948
Pharmacological actions of the ethylaminoethyl ester of phenyl-cyclopentane-carboxylic acid (parpanit). Archives internationales de pharmacodynamie et de therapie, 1948, Jan-15, Volume: 75, Issue:3-4 Topics: Cyclopentanes	1948
Clinical results with parpanit. Praxis, 1948, Mar-04, Volume: 37, Issue:9 Topics: Cyclopentanes	1948
Pharmacological research on the ethylaminoethyl ester of phenylcyclopentanecarbonic acid (parpanit). Schweizerische medizinische Wochenschrift, 1948, Mar-13, Volume: 78, Issue:10 Topics: Cyclopentanes	1948
Mode of action of Parpanit on the nervous functions of the normal organism. Helvetica physiologica et pharmacologica acta, 1948, Volume: 6, Issue:3 Topics: Cyclopentanes	1948
Isobolographic analysis of caramiphen and lidocaine on spinal anesthesia in rats. Neuroscience letters, 2010, Jan-18, Volume: 469, Issue:1 Topics: Anesthesia, Spinal; Anesthetics, Combined; Anesthetics, Local; Animals; Cyclopentanes; Dose-Response Relationship, Drug; Drug Synergism; Injections, Spinal; Lidocaine; Male; Rats; Rats, Sprague-Dawley	2010
Parpanit Geigy. Schweizerische Apotheker Zeitung, 1947, Mar-22, Volume: 85, Issue:12 Topics: Cyclopentanes	1947
The parpanit in neurological practice. Therapeutische Umschau und medizinische Bibliographie. Revue therapeutique et bibliographie medicale, 1947, Volume: 3, Issue:11 Topics: Cyclopentanes	1947
A new therapy for extra-pyramidal motor disorders: "Parpanit". Medecine et hygiene, 1947, Jan-01, Volume: 5, Issue:89 Topics: Brain; Cyclopentanes; Extrapyramidal Tracts; Humans; Movement Disorders; Nervous System	1947
About Parpanit, a new substance that influences extrapyramidal movement disorders. Praxis, 1947, Jan-16, Volume: 36, Issue:3 Topics: Basal Ganglia Diseases; Cyclopentanes; Extrapyramidal Tracts; Humans	1947
Clinical experience in treating extrapyramidal disorders with a new agent, parpanit. Praxis, 1947, Jan-16, Volume: 36, Issue:3 Topics: Basal Ganglia Diseases; Cyclopentanes; Extrapyramidal Tracts; Humans	1947
Antidepressant-like effect of centrally acting non-narcotic antitussive caramiphen in a forced swimming test. Neuroscience letters, 2010, Sep-13, Volume: 481, Issue:3 Topics: Animals; Antidepressive Agents; Antitussive Agents; Behavior, Animal; Cyclopentanes; Male; Motor Activity; Rats; Rats, Wistar; Stress, Psychological; Swimming	2010
Neuroprotective efficacy of caramiphen against soman and mechanisms of its action. British journal of pharmacology, 2011, Volume: 164, Issue:5 Topics: Animals; Behavior, Animal; Brain; Cell Count; Chemical Warfare Agents; Cyclopentanes; Dose-Response Relationship, Drug; Male; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, GABA-A; Receptors, N-Methyl-D-Aspartate; Seizures; Soman; Synaptic Potentials	2011
Enhanced efficacy of anticonvulsants when combined with levetiracetam in soman-exposed rats. Neurotoxicology, 2011, Volume: 32, Issue:6 Topics: Animals; Anticonvulsants; Antidotes; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterase Reactivators; Cyclopentanes; Disease Models, Animal; Drug Therapy, Combination; Lethal Dose 50; Levetiracetam; Male; Motor Activity; Muscimol; Nicotinic Antagonists; Piracetam; Procyclidine; Quinoxalines; Rats; Rats, Wistar; Reaction Time; Seizures; Soman; Time Factors	2011
The anticholinergic and antiglutamatergic drug caramiphen reduces seizure duration in soman-exposed rats: synergism with the benzodiazepine diazepam. Toxicology and applied pharmacology, 2012, Mar-15, Volume: 259, Issue:3 Topics: Acetylcholinesterase; Animals; Anticonvulsants; Body Temperature; Body Weight; Cholinergic Antagonists; Cholinesterase Inhibitors; Cyclopentanes; Diazepam; Dose-Response Relationship, Drug; Drug Synergism; Male; Rats; Rats, Sprague-Dawley; Seizures; Soman; Time Factors	2012
Magnesium sulfate treatment against sarin poisoning: dissociation between overt convulsions and recorded cortical seizure activity. Archives of toxicology, 2013, Volume: 87, Issue:2 Topics: Animals; Anticonvulsants; Antidotes; Brain Injuries; Cerebral Cortex; Chemical Warfare Agents; Cyclopentanes; Epilepsy, Tonic-Clonic; Magnesium Sulfate; Male; Midazolam; Rats; Rats, Sprague-Dawley; Sarin; Seizures; Telemetry	2013
The perirhinal cortex of rats: an intricate area for microinfusion of anticonvulsants against soman-induced seizures. Neurotoxicology, 2013, Volume: 34 Topics: Animals; Anticonvulsants; Brain Waves; Catheters, Indwelling; Cerebral Cortex; Cyclopentanes; Cyclopropanes; Disease Models, Animal; Drug Delivery Systems; Electroencephalography; Glycine; Infusions, Parenteral; Male; Micromanipulation; Procyclidine; Pyridines; Rats; Rats, Wistar; Reaction Time; Seizures; Soman; Time Factors	2013
FOLICation: engineering approved drugs as potential p53-MDM2 interaction inhibitors for cancer therapy. Medical hypotheses, 2013, Volume: 81, Issue:6 Topics: Clofazimine; Cyclopentanes; Drug Discovery; Folic Acid; Humans; Imidazoles; Indoles; Models, Molecular; Neoplasms; Piperazines; Protein Interaction Domains and Motifs; Proto-Oncogene Proteins c-mdm2; Spiro Compounds; Tumor Suppressor Protein p53	2013
Caramiphen-induced block of sodium currents and spinal anesthesia. European journal of pharmacology, 2015, Jan-05, Volume: 746 Topics: Anesthesia, Spinal; Anesthetics, Local; Animals; Behavior, Animal; Cell Line; Cyclopentanes; Dose-Response Relationship, Drug; Humans; Injections, Spinal; Male; Membrane Potentials; Mice; Motor Activity; Nerve Tissue Proteins; Neurons; Nociception; Patch-Clamp Techniques; Rats, Sprague-Dawley; Voltage-Gated Sodium Channel Blockers; Voltage-Gated Sodium Channels	2015
Comparing the Antiseizure and Neuroprotective Efficacy of LY293558, Diazepam, Caramiphen, and LY293558-Caramiphen Combination against Soman in a Rat Model Relevant to the Pediatric Population. The Journal of pharmacology and experimental therapeutics, 2018, Volume: 365, Issue:2 Topics: Animals; Anticonvulsants; Anxiety; Basolateral Nuclear Complex; Behavior, Animal; Child; Cyclopentanes; Diazepam; Disease Models, Animal; Drug Interactions; Humans; Isoquinolines; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Soman; Status Epilepticus; Tetrazoles	2018
Full Protection Against Soman-Induced Seizures and Brain Damage by LY293558 and Caramiphen Combination Treatment in Adult Rats. Neurotoxicity research, 2018, Volume: 34, Issue:3 Topics: Animals; Anticonvulsants; Body Weight; Brain Injuries; Brain Waves; Cholinesterase Inhibitors; Cyclopentanes; Disease Models, Animal; Drug Therapy, Combination; Electroencephalography; Fluoresceins; Fourier Analysis; Isoquinolines; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Seizures; Soman; Tetrazoles; Time Factors	2018
Electroencephalographic analysis in soman-exposed 21-day-old rats and the effects of midazolam or LY293558 with caramiphen. Annals of the New York Academy of Sciences, 2020, Volume: 1479, Issue:1 Topics: Animals; Antidotes; Cyclopentanes; Electrocardiography; Isoquinolines; Male; Midazolam; Nerve Agents; Rats; Rats, Sprague-Dawley; Soman; Status Epilepticus; Tetrazoles	2020